Clinical trial
Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis
NCT02559869 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2015
- Completion date
- June 28, 2019
- Enrollment
- 86 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
amyotrophic lateral sclerosis (als)